Task force report on “non-criteria” antiphospholipid antibody tests

Maria Laur A. Bertolaccini; Olg A. Amengual; Tatsuy A. Atsumi; Walter L. Binder; William H. Kutteh; Bas De Laat; Ricardo Forastiero; Marc Lambert; Hidehiko Matsubayashi; Vijaya L. Murthy; Michelle Petri; Jacob H. Rand; Marielle Sanmarco; Anne E. Tebo; Silvia S. Pierangeli

doi:10.1007/978-1-4614-3194-7_8

Task force report on “non-criteria” antiphospholipid antibody tests

Maria Laur A. Bertolaccini, Olg A. Amengual, Tatsuy A. Atsumi, Walter L. Binder, William H. Kutteh, Bas De Laat, Ricardo Forastiero, Marc Lambert, Hidehiko Matsubayashi, Vijaya L. Murthy, Michelle Petri, Jacob H. Rand, Marielle Sanmarco, Anne E. Tebo, Silvia S. Pierangeli

Internal Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Current classification criteria for antiphospholipid syndrome (APS) recommend the use of one or more of three positive standardized laboratory assays to detect antiphospholipid antibodies (aPL) in the presence of at least one of the two major clinical manifestations (i.e., thrombosis or pregnancy morbidity). However, several other autoantibodies shown to be directed against phospholipids other than cardiolipin and/or their complexes with proteins of the coagulation cascade have also been proposed to be important in APS. This chapter summarizes the recommendations of a Task Force of worldwide scientists who discussed and analyzed critical questions related to “noncriteria” aPL tests in an evidence-based manner, during the 13th International Congress on Antiphospholipid Antibodies (APLA 2010, April 13–16, 2010, Galveston, TX).

Original language	English (US)
Title of host publication	Antiphospholipid Syndrome
Subtitle of host publication	Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies
Publisher	Springer US
Pages	134-146
Number of pages	13
ISBN (Electronic)	9781461431947
ISBN (Print)	9781461431930
DOIs	https://doi.org/10.1007/978-1-4614-3194-7_8
State	Published - Jan 1 2012

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-4614-3194-7_8

Cite this

Bertolaccini, M. L. A., Amengual, O. A., Atsumi, T. A., Binder, W. L., Kutteh, W. H., De Laat, B., Forastiero, R., Lambert, M., Matsubayashi, H., Murthy, V. L., Petri, M., Rand, J. H., Sanmarco, M., Tebo, A. E., & Pierangeli, S. S. (2012). Task force report on “non-criteria” antiphospholipid antibody tests. In Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies (pp. 134-146). Springer US. https://doi.org/10.1007/978-1-4614-3194-7_8

Task force report on “non-criteria” antiphospholipid antibody tests. / Bertolaccini, Maria Laur A.; Amengual, Olg A.; Atsumi, Tatsuy A. et al.
Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies. Springer US, 2012. p. 134-146.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Bertolaccini, MLA, Amengual, OA, Atsumi, TA, Binder, WL, Kutteh, WH, De Laat, B, Forastiero, R, Lambert, M, Matsubayashi, H, Murthy, VL, Petri, M, Rand, JH, Sanmarco, M, Tebo, AE & Pierangeli, SS 2012, Task force report on “non-criteria” antiphospholipid antibody tests. in Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies. Springer US, pp. 134-146. https://doi.org/10.1007/978-1-4614-3194-7_8

@inbook{794d359dde6244b2af98749ed130b1cf,

title = "Task force report on “non-criteria” antiphospholipid antibody tests",

abstract = "Current classification criteria for antiphospholipid syndrome (APS) recommend the use of one or more of three positive standardized laboratory assays to detect antiphospholipid antibodies (aPL) in the presence of at least one of the two major clinical manifestations (i.e., thrombosis or pregnancy morbidity). However, several other autoantibodies shown to be directed against phospholipids other than cardiolipin and/or their complexes with proteins of the coagulation cascade have also been proposed to be important in APS. This chapter summarizes the recommendations of a Task Force of worldwide scientists who discussed and analyzed critical questions related to “noncriteria” aPL tests in an evidence-based manner, during the 13th International Congress on Antiphospholipid Antibodies (APLA 2010, April 13–16, 2010, Galveston, TX).",

author = "Bertolaccini, {Maria Laur A.} and Amengual, {Olg A.} and Atsumi, {Tatsuy A.} and Binder, {Walter L.} and Kutteh, {William H.} and {De Laat}, Bas and Ricardo Forastiero and Marc Lambert and Hidehiko Matsubayashi and Murthy, {Vijaya L.} and Michelle Petri and Rand, {Jacob H.} and Marielle Sanmarco and Tebo, {Anne E.} and Pierangeli, {Silvia S.}",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2012.",

year = "2012",

month = jan,

day = "1",

doi = "10.1007/978-1-4614-3194-7_8",

language = "English (US)",

isbn = "9781461431930",

pages = "134--146",

booktitle = "Antiphospholipid Syndrome",

publisher = "Springer US",

}

TY - CHAP

T1 - Task force report on “non-criteria” antiphospholipid antibody tests

AU - Bertolaccini, Maria Laur A.

AU - Amengual, Olg A.

AU - Atsumi, Tatsuy A.

AU - Binder, Walter L.

AU - Kutteh, William H.

AU - De Laat, Bas

AU - Forastiero, Ricardo

AU - Lambert, Marc

AU - Matsubayashi, Hidehiko

AU - Murthy, Vijaya L.

AU - Petri, Michelle

AU - Rand, Jacob H.

AU - Sanmarco, Marielle

AU - Tebo, Anne E.

AU - Pierangeli, Silvia S.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Current classification criteria for antiphospholipid syndrome (APS) recommend the use of one or more of three positive standardized laboratory assays to detect antiphospholipid antibodies (aPL) in the presence of at least one of the two major clinical manifestations (i.e., thrombosis or pregnancy morbidity). However, several other autoantibodies shown to be directed against phospholipids other than cardiolipin and/or their complexes with proteins of the coagulation cascade have also been proposed to be important in APS. This chapter summarizes the recommendations of a Task Force of worldwide scientists who discussed and analyzed critical questions related to “noncriteria” aPL tests in an evidence-based manner, during the 13th International Congress on Antiphospholipid Antibodies (APLA 2010, April 13–16, 2010, Galveston, TX).

AB - Current classification criteria for antiphospholipid syndrome (APS) recommend the use of one or more of three positive standardized laboratory assays to detect antiphospholipid antibodies (aPL) in the presence of at least one of the two major clinical manifestations (i.e., thrombosis or pregnancy morbidity). However, several other autoantibodies shown to be directed against phospholipids other than cardiolipin and/or their complexes with proteins of the coagulation cascade have also been proposed to be important in APS. This chapter summarizes the recommendations of a Task Force of worldwide scientists who discussed and analyzed critical questions related to “noncriteria” aPL tests in an evidence-based manner, during the 13th International Congress on Antiphospholipid Antibodies (APLA 2010, April 13–16, 2010, Galveston, TX).

UR - http://www.scopus.com/inward/record.url?scp=84949435661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949435661&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-3194-7_8

DO - 10.1007/978-1-4614-3194-7_8

M3 - Chapter

AN - SCOPUS:84949435661

SN - 9781461431930

SP - 134

EP - 146

BT - Antiphospholipid Syndrome

PB - Springer US

ER -

Task force report on “non-criteria” antiphospholipid antibody tests

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this